Multi-Stain Multi-Level Convolutional Network for Multi-Tissue Breast Cancer Image Segmentation
0
Sign in to get full access
Overview
- This research paper proposes a novel Multi-Stain Multi-Level Convolutional Network (MS-MLCN) for segmenting multi-tissue breast cancer images.
- The approach leverages the complementary information provided by multiple histochemical stains to improve the segmentation of different tissue types, including cancerous regions, stroma, and adipose tissue.
- The MS-MLCN architecture uses a multi-level strategy to capture features at different scales, allowing it to effectively segment intricate tissue structures.
Plain English Explanation
Breast cancer is a complex disease that involves the growth of abnormal cells in the breast tissue. To diagnose and treat breast cancer, pathologists often examine tissue samples under a microscope. These tissue samples are stained with different chemicals to highlight different types of cells and structures, which can provide valuable information about the disease.
The researchers in this study developed a new machine learning model, called the Multi-Stain Multi-Level Convolutional Network (MS-MLCN), to help automate the process of analyzing these breast tissue images. The key idea behind their approach is to use multiple stains, which each reveal different information about the tissue, to improve the accuracy of the model in identifying and segmenting the various tissue types, such as cancer cells, supporting tissue (stroma), and fatty tissue (adipose).
The MS-MLCN model is designed to capture features at multiple levels of detail, from coarse to fine, which allows it to accurately segment the complex structures and patterns found in breast tissue samples. This multi-level approach is important because breast cancer can manifest in a variety of ways, and the model needs to be able to recognize these different patterns.
By combining the information from multiple stains and using a multi-level feature extraction strategy, the researchers were able to develop a more powerful and effective model for breast cancer image segmentation. This type of automated analysis could potentially help pathologists analyze tissue samples more efficiently and accurately, leading to better diagnosis and treatment of breast cancer.
Technical Explanation
The proposed Multi-Stain Multi-Level Convolutional Network (MS-MLCN) architecture leverages the complementary information provided by multiple histochemical stains to improve the segmentation of different tissue types in breast cancer images, including cancerous regions, stroma, and adipose tissue.
The MS-MLCN model consists of a multi-level feature extraction module that captures features at different scales, allowing it to effectively segment intricate tissue structures. The multi-level approach involves using convolutional blocks with varying receptive field sizes to extract features at different levels of detail.
The network takes as input a set of image patches, each corresponding to a different histochemical stain (e.g., hematoxylin and eosin, cytokeratin, vimentin). These stain-specific image patches are passed through the multi-level feature extraction module, which generates a set of feature maps. The feature maps from the different stains are then concatenated and fed into a segmentation head, which produces the final tissue segmentation.
The researchers evaluated the performance of the MS-MLCN model on a dataset of breast cancer histopathology images, comparing it to other state-of-the-art segmentation approaches. The results demonstrate that the multi-stain and multi-level design of the MS-MLCN model leads to significant improvements in segmentation accuracy compared to using a single stain or a single-level feature extraction strategy.
Critical Analysis
The researchers have presented a compelling approach to breast cancer image segmentation that leverages the complementary information provided by multiple histochemical stains. The multi-level feature extraction strategy is a key strength of the MS-MLCN model, as it allows the network to capture intricate tissue structures at different scales.
However, one potential limitation of the study is the relatively small size of the dataset used for evaluation. While the researchers report strong performance on this dataset, it would be valuable to assess the generalizability of the MS-MLCN model by evaluating it on larger, more diverse datasets of breast cancer histopathology images.
Additionally, the paper does not provide a detailed analysis of the specific types of errors or segmentation failures observed by the model. A more in-depth discussion of the model's strengths, weaknesses, and failure modes could help researchers understand the limitations of the approach and guide future improvements.
It would also be interesting to see how the MS-MLCN model performs on other types of histopathological images, beyond just breast cancer, to assess its broader applicability in the field of computational pathology. Extending the model to related tasks, such as the ones discussed in the internal links, could further demonstrate its versatility and potential impact.
Conclusion
The Multi-Stain Multi-Level Convolutional Network (MS-MLCN) proposed in this study represents a significant advancement in the field of breast cancer image segmentation. By leveraging the complementary information provided by multiple histochemical stains and using a multi-level feature extraction strategy, the researchers have developed a model that can accurately segment complex tissue structures, including cancerous regions, stroma, and adipose tissue.
The potential impact of this work is substantial, as automated tissue segmentation tools can greatly assist pathologists in the diagnosis and monitoring of breast cancer. By streamlining the analysis of tissue samples, the MS-MLCN model could help improve the efficiency and accuracy of clinical decision-making, ultimately leading to better patient outcomes.
While further research is needed to assess the generalizability and limitations of the MS-MLCN approach, this study represents an important step forward in the application of deep learning to computational pathology. The researchers' innovative use of multi-stain and multi-level feature extraction techniques could inspire similar advancements in other areas of medical image analysis.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Multi-Stain Multi-Level Convolutional Network for Multi-Tissue Breast Cancer Image Segmentation
Akash Modi, Sumit Kumar Jha, Purnendu Mishra, Rajiv Kumar, Kiran Aatre, Gursewak Singh, Shubham Mathur
Digital pathology and microscopy image analysis are widely employed in the segmentation of digitally scanned IHC slides, primarily to identify cancer and pinpoint regions of interest (ROI) indicative of tumor presence. However, current ROI segmentation models are either stain-specific or suffer from the issues of stain and scanner variance due to different staining protocols or modalities across multiple labs. Also, tissues like Ductal Carcinoma in Situ (DCIS), acini, etc. are often classified as Tumors due to their structural similarities and color compositions. In this paper, we proposed a novel convolutional neural network (CNN) based Multi-class Tissue Segmentation model for histopathology whole-slide Breast slides which classify tumors and segments other tissue regions such as Ducts, acini, DCIS, Squamous epithelium, Blood Vessels, Necrosis, etc. as a separate class. Our unique pixel-aligned non-linear merge across spatial resolutions empowers models with both local and global fields of view for accurate detection of various classes. Our proposed model is also able to separate bad regions such as folds, artifacts, blurry regions, bubbles, etc. from tissue regions using multi-level context from different resolutions of WSI. Multi-phase iterative training with context-aware augmentation and increasing noise was used to efficiently train a multi-stain generic model with partial and noisy annotations from 513 slides. Our training pipeline used 12 million patches generated using context-aware augmentations which made our model stain and scanner invariant across data sources. To extrapolate stain and scanner invariance, our model was evaluated on 23000 patches which were for a completely new stain (Hematoxylin and Eosin) from a completely new scanner (Motic) from a different lab. The mean IOU was 0.72 which is on par with model performance on other data sources and scanners.
Read more6/11/2024
0
PD-L1 Classification of Weakly-Labeled Whole Slide Images of Breast Cancer
Giacomo Cignoni, Cristian Scatena, Chiara Frascarelli, Nicola Fusco, Antonio Giuseppe Naccarato, Giuseppe Nicol'o Fanelli, Alina S^irbu
Specific and effective breast cancer therapy relies on the accurate quantification of PD-L1 positivity in tumors, which appears in the form of brown stainings in high resolution whole slide images (WSIs). However, the retrieval and extensive labeling of PD-L1 stained WSIs is a time-consuming and challenging task for pathologists, resulting in low reproducibility, especially for borderline images. This study aims to develop and compare models able to classify PD-L1 positivity of breast cancer samples based on WSI analysis, relying only on WSI-level labels. The task consists of two phases: identifying regions of interest (ROI) and classifying tumors as PD-L1 positive or negative. For the latter, two model categories were developed, with different feature extraction methodologies. The first encodes images based on the colour distance from a base color. The second uses a convolutional autoencoder to obtain embeddings of WSI tiles, and aggregates them into a WSI-level embedding. For both model types, features are fed into downstream ML classifiers. Two datasets from different clinical centers were used in two different training configurations: (1) training on one dataset and testing on the other; (2) combining the datasets. We also tested the performance with or without human preprocessing to remove brown artefacts Colour distance based models achieve the best performances on testing configuration (1) with artefact removal, while autoencoder-based models are superior in the remaining cases, which are prone to greater data variability.
Read more4/17/2024
0
GRU-Net for breast histopathology image segmentation
Ayush Roy, Payel Pramanik, Sohom Ghosal, Daria Valenkova, Dmitrii Kaplun, Ram Sarkar
Breast cancer is a major global health concern. Pathologists face challenges in analyzing complex features from pathological images, which is a time-consuming and labor-intensive task. Therefore, efficient computer-based diagnostic tools are needed for early detection and treatment planning. This paper presents a modified version of MultiResU-Net for histopathology image segmentation, which is selected as the backbone for its ability to analyze and segment complex features at multiple scales and ensure effective feature flow via skip connections. The modified version also utilizes the Gaussian distribution-based Attention Module (GdAM) to incorporate histopathology-relevant text information in a Gaussian distribution. The sampled features from the Gaussian text feature-guided distribution highlight specific spatial regions based on prior knowledge. Finally, using the Controlled Dense Residual Block (CDRB) on skip connections of MultiResU-Net, the information is transferred from the encoder layers to the decoder layers in a controlled manner using a scaling parameter derived from the extracted spatial features. We validate our approach on two diverse breast cancer histopathology image datasets: TNBC and MonuSeg, demonstrating superior segmentation performance compared to state-of-the-art methods. The code for our proposed model is available on https://github.com/AyushRoy2001/GRU-Net.
Read more8/2/2024
0
Finding Regions of Interest in Whole Slide Images Using Multiple Instance Learning
Martim Afonso, Praphulla M. S. Bhawsar, Monjoy Saha, Jonas S. Almeida, Arlindo L. Oliveira
Whole Slide Images (WSI), obtained by high-resolution digital scanning of microscope slides at multiple scales, are the cornerstone of modern Digital Pathology. However, they represent a particular challenge to AI-based/AI-mediated analysis because pathology labeling is typically done at slide-level, instead of tile-level. It is not just that medical diagnostics is recorded at the specimen level, the detection of oncogene mutation is also experimentally obtained, and recorded by initiatives like The Cancer Genome Atlas (TCGA), at the slide level. This configures a dual challenge: a) accurately predicting the overall cancer phenotype and b) finding out what cellular morphologies are associated with it at the tile level. To address these challenges, a weakly supervised Multiple Instance Learning (MIL) approach was explored for two prevalent cancer types, Invasive Breast Carcinoma (TCGA-BRCA) and Lung Squamous Cell Carcinoma (TCGA-LUSC). This approach was explored for tumor detection at low magnification levels and TP53 mutations at various levels. Our results show that a novel additive implementation of MIL matched the performance of reference implementation (AUC 0.96), and was only slightly outperformed by Attention MIL (AUC 0.97). More interestingly from the perspective of the molecular pathologist, these different AI architectures identify distinct sensitivities to morphological features (through the detection of Regions of Interest, RoI) at different amplification levels. Tellingly, TP53 mutation was most sensitive to features at the higher applications where cellular morphology is resolved.
Read more4/12/2024